In a consensus report published last week, Endocrine therapy and related issues in hormone receptor‑positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG), the BCTEG addressed four gaps in current guidance for oncologists related to the most common form of breast cancer, estrogen receptor positive (ER+) early stage breast […]
December marked another busy month that included a few exciting days at the 2016 San Antonio Breast Cancer Symposium (SABCS), a five-day conference geared toward an international community of more than 7,000 physicians, researchers, and advocates. The purpose of the annual meeting is to share and discuss data and insights from groundbreaking research on breast […]
ASCO is the largest (30,000+ oncology professionals) cancer meeting for sharing new scientific findings that may alter the way patients are diagnosed, treated and followed.
This year’s ASCO, which focused on patient-centered care and research, featured many important developments in the field of ER+ breast cancer.
We reviewed 150+ data presentations and have summarized some of the diagnostic, treatment and side effect management presentations to share with you.